Latest Breaking News On - Vertex pharmaceuticals price performance - Page 5 : comparemela.com

Vertex Pharmaceuticals (NASDAQ:VRTX) Downgraded by StockNews com

StockNews.com lowered shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a strong-buy rating to a buy rating in a report released on Saturday morning. VRTX has been the subject of several other research reports. Wells Fargo & Company boosted their target price on shares of Vertex Pharmaceuticals from $500.00 to $540.00 and gave the […]

United statesSanfordc bernsteinOurania tatsisAmit sachdevCanaccord genuity groupWells fargo companyNorges bankJpmorgan chase coHedge funds weigh in on vertex pharmaceuticalsAnalyst recommendations for vertex pharmaceuticalsCantor fitzgeraldPublic employees retirement association of coloradoVertex pharmaceuticals price performanceVertex pharmaceuticals incorporatedNews ratings for vertex pharmaceuticals dailyVertex pharmaceuticals company profile

California Public Employees Retirement System Has $616 77 Million Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

California Public Employees Retirement System Has $616 77 Million Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesRobertw bairdStuarta arbuckleOurania tatsisQuarter for vertex pharmaceuticalsInsider transactions at vertex pharmaceuticalsVertex pharmaceuticals price performanceCanaccord genuity groupSecurities exchange commissionVertex pharmaceuticalsGlobal retirement partnersHb wealth managementFirst affirmative financial networkExchange commissionVertex pharmaceuticals incorporatedVertex pharmaceuticals company profile

Greenleaf Trust Increases Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Greenleaf Trust Increases Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Ourania tatsisRobertw bairdStuarta arbuckleFortitude family officeSecurities exchange commissionVertex pharmaceuticals price performanceArlington trust coQuarter for vertex pharmaceuticalsMaxim groupExchange commissionVertex pharmaceuticals profileVertex pharmaceuticalsRoyal bankBaystate wealth managementCompass wealth managementNews ratings for vertex pharmaceuticals daily

Calamos Advisors LLC Trims Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Calamos Advisors LLC Trims Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Sanfordc bernsteinOurania tatsisVertex pharmaceuticalsCantor fitzgeraldVertex pharmaceuticals incorporatedNews ratings for vertex pharmaceuticals dailyMacquarie group ltdMan groupSecurities exchange commissionVertex pharmaceuticals price performanceMorgan stanleyCalamos advisorsQuarter for vertex pharmaceuticalsJpmorgan chase coNorges bankFree report

NBW Capital LLC Acquires 8,145 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

NBW Capital LLC lifted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 72.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,432 shares of the pharmaceutical company’s stock after buying an additional 8,145 shares during the period. […]

Amit sachdevOurania tatsisRobertw bairdGeode capital managementMorgan stanleyQuarter for vertex pharmaceuticalsVertex pharmaceuticalsVanguard group incNews ratings for vertex pharmaceuticals dailyRoyal bankVertex pharmaceuticals incorporatedNbw capitalJpmorgan chase coVertex pharmaceuticals price performanceCanaccord genuity groupSecurities exchange commission